SLC1A5 and ovarian cancer: By contrast, the expression of ASCT2 is not a significant prognostic factor of worse clinical outcomes in ovarian cancer, although positive expression of LAT1 is closely correlated with that of ASCT2 and CD98hc, and leads to significantly worse outcomes [91,92,93].